Case of polymorphic ventricular tachycardia in diphenhydramine poisoning

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 5, 2004, Pages 591-593

  Joshi, Ajay K ^a   Sljapic, Tatjana ^a   Borghei, Hassan ^a   Kowey, Peter R ^a  

^a 556 Lankenau MOB East ^*

Author keywords

Diphenhydramine; IKr channel; Overdose; QT prolongation; Torsades de pointes

Indexed keywords

BICARBONATE; CHARCOAL; DIPHENHYDRAMINE; ELECTROLYTE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; DISEASE ACTIVITY; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROCARDIOGRAM; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LABORATORY TEST; MALE; PALLIATIVE THERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QT PROLONGATION; TREATMENT OUTCOME;

EID: 2442575876     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03173.x     Document Type: Article

References (15)

1. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Cobaugh DJ, Youniss J, Omslaer JC, May ME, Woolf AD, Benson BE: 2001 Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 2002;20:391-452.
2. Clark RF, Vance MV: Massive diphenhydramine poisoning resulting in a wide-complex tachycardia: Successful treatment with sodium bicarbonate. Ann Emerg Med 1992;21:318-321.
3. Radovanovic D, Meier PJ, Guirguis M, Lorent JP, Kupferschmidt H: Dose dependent toxicity of diphenhydramine overdose. Hum Exp Toxicol 2000;19:489-495.
4. Zareba W, Moss AJ, Rosero SZ, Rosero SZ, Hajj-Ali R, Konecki J, Andrews M: Electrocardiographic findings in patients with diphenhydramine overdose. Am J Cardiol 1997;80:1168-1173.
5. Koppel C, Ibe K, Tenczer J: Clinical symptomatology of diphenhydramine overdose: An evaluation of 136 cases in 1982 to 1985. Clin Toxicol 1987;25:53-70.
6. Weidmann S: The effects of the cardiac membrane potential on the rapid availability of the sodium carrying system. J Physiol (Lond) 1955;127:213-224.
7. + current by diphenhydramine and other diphenyl compounds: Molecular determinants of selective binding to the inactivated channels. Mol Pharmacol 2000;57:135-143.
8. Woosley RL: Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 1996;36:233-252.
9. Moss AJ, Zareba W, Benhorin J, Locate EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH, Keating MT, MacCluer JW, Timothy KW: Electrocardiographic T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.
10. Roden DM: Current status of class III antiarrhythmic therapy. Am J Cardiol 1993;72:44B-49B.
11. Vos MA, Verduyn SC, Gorgels APM, Lipcsei GC, Wellens HJJ: Reproducible induction of early afterdepolarization and torsades de pointes arrhythmia by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91:864-872.
12. Kr. Implications for torsades de pointes and reverse use-dependence. Circulation 1996;93:407-411.
13. Sanding T, Ogawa S, Okada Y, Tsutsumi N, Iwanaga S, Yoshikawa T, Akaishi M, Handa S: Clinical evaluation of the use dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy. Am Heart J 1993;126:114-121.
14. Grant AO, Trantham JL, Brown KK, et al: pH dependent effects of quinidine on the kinetics of dV/dtmax in guinea pig ventricular myocardium. Circ Res 1982;50:210-217.
15. Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL, Roden DM: Allelic variants in long QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002;105:1943-1948.